Probiotic sepsis in preterm neonates-a systematic review
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Sepsis due to the administered probiotic strain/s is a barrier against adoption of prophylactic probiotic supplementation in preterm infants to reduce the risk of necrotising enterocolitis (NEC ≥ Stage II), all-cause mortality, late-onset sepsis, and feeding intolerance. We aimed to conduct a systematic review for reports of probiotic sepsis in preterm infants (gestation < 37 weeks). Databases including PubMed, Embase, Emcare, Cochrane Central library, and Google Scholar were searched in August 2021 and updated in Jan 2022. Probiotic sepsis was defined as positive blood/CSF culture isolating administered probiotic strain with symptoms suggestive of infection. Data collection included birth weight, gestation, comorbidities (e.g. gut surgery, NEC), presence of central venous catheters, treatment, and outcome. Literature search revealed 1569 studies. A total of 16 reports [randomised control trial (RCT): none; non-RCT: 1; case series: 8; case report: 7] involving 32 preterm infants with probiotic sepsis were included after exclusions for various reasons. Majority of the cases were born < 32 weeks' gestation. Bifidobacterium (N = 19) was the most commonly isolated organism followed by Lactobacillus (N = 10), and Saccharomyces (N = 3). A total of 25/32 cases were confirmed to be due to the administered probiotic strain on full genomic analysis. Two studies reported one neonatal death each. Twelve neonates had comorbidities. Majority were treated with antibiotics (29/32) whereas others (3/32) required antifungal treatment.Conclusion Probiotics sepsis is relatively an uncommon event in preterm infants. Majority of the cases recovered after antibiotic or antifungal treatment. The importance of optimal surveillance and treatment of probiotic sepsis and research towards alternatives to probiotics (e.g. postbiotics) is emphasised.What is known • Probiotics have been shown to reduce necrotising enterocolitis, late-onset sepsis, all-cause mortality, and time to reach full enteral feeds in preterm infants. • Despite the evidence, use of probiotics is not universal due to concerns regarding probiotic-associated sepsis in preterm infants.What is new • This comprehensive systematic review showed that probiotic sepsis is a relatively rare phenomenon in preterm infants. • All except one case where the diagnosis was uncertain recovered after antimicrobial therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A review of 1569 studies reporting sepsis in preterm neonates found only 32 cases associated with either Bifidobacterium or Lactobacillus strains [39].”
From Lactobacillus Bacteremia and Probiotics: A Review (2023) · cites this paper as [39]
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Review article: yeast as probiotics – Saccharomyces boulardii
CZERUCKA, D., PICHE, T., & RAMPAL, P. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03442.x · Cited by 587 · cited 2×
“Being antibiotic-resistant, Saccharomyces has an advantage as a probiotic [33, 34].”
BackgroundSystematic review and meta-analysis of Saccharomyces boulardii in adult patients
McFarland, L. V. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i18.2202 · Cited by 545
Lin, H.-C., Hsu, C.-H., Chen, H.-L., Chung, M.-Y., Hsu, J.-F., Lien, R.-I., Tsao, L.-Y., Chen, C.-H., & Su, B.-H. (2008) · Pediatrics · doi:10.1542/peds.2007-3007 · Cited by 506
Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases · doi:10.1086/429916 · Cited by 462 · cited 1×
“Minimising the risk of environmental contamination is important considering the report of invasive fungal infection in critically ill adults receiving Saccharomyces probiotics [35].”
BackgroundSu, G. L., Ko, C. W., Bercik, P., Falck-Ytter, Y., Sultan, S., Weizman, A. V., & Morgan, R. L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.059 · Cited by 421
Salminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., & Järvinen, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342912 · Cited by 419 · cited 1×
“Finland and Sweden have reported no significant increase in Lactobacillus-related invasive infections despite the introduction of such probiotics at population level [37, 38].”
BackgroundBifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial
Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., & Millar, M. R. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01027-2 · Cited by 387
Kelesidis, T., & Pothoulakis, C. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11428502 · Cited by 377
Probiotic Effects on Late-onset Sepsis in Very Preterm Infants: A Randomized Controlled Trial
Jacobs, S. E., Tobin, J. M., Opie, G. F., Donath, S., Tabrizi, S. N., Pirotta, M., Morley, C. J., & Garland, S. M. (2013) · Pediatrics · doi:10.1542/peds.2013-1339 · Cited by 327
Research works printed but not linked: 4
- Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford
- Celis Castañeda LA, Morales Camacho WJ, Durán Ochoa NM (2019) Sepsis due to Lactobacillus reuteri in an extreme preterm newborn: case report. Arch Argent Pediatr 117:e509–e513
- Chiang M-C, Chen C-L, Feng Y, Chen C-C, Lien R, Chiu C-H (2020) Lactobacillus rhamnosus sepsis associated with probiotic therapy in an extremely preterm infant: Pathogenesis and a review for clinicians. J Microbiol Immunol Infect · DOI · Paper page
- Vallabhaneni S, Walker TA, Lockhart SR, Ng D, Branch IDP, Chiller T, Melchreit R, Brandt ME, Smith RM (2015) Fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement—Connecticut, 2014. MMWR Morb Mortal Wkly Rep 64:155
Cited by
Lactobacillus Bacteremia and Probiotics: A Review
Kullar, R., Goldstein, E. J. C., Johnson, S., & McFarland, L. V. (2023) · Microorganisms · doi:10.3390/microorganisms11040896 · Cited by 156
“LB has been reported in patients with cancer [10,31–33], ischemic or ulcerative colitis [34,35], that are immunocompromised (HIV, chronic steroids, chemotherapy, or transplant patients) [36–38], or in preterm neonates with underlying conditions (short bowel syndrome, growth restriction) [39].”
Background(BIOHAZ), E. P. O. B. H., Koutsoumanis, K., Allende, A., Alvarez‐Ordóñez, A., Bolton, D., Bover‐Cid, S., Chemaly, M., De Cesare, A., Hilbert, F., Lindqvist, R., et al. (2023) · EFSA Journal · doi:10.2903/j.efsa.2023.7746 · Cited by 56
“Another (Kulkarni, 2022) was a review paper in pre-term neonates.”
BackgroundBargheet, A., Klingenberg, C., Esaiassen, E., Hjerde, E., Cavanagh, J. P., Bengtsson-Palme, J., & Pettersen, V. K. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104613 · Cited by 52
Effectiveness and Risks of Probiotics in Preterm Infants
Alshaikh, B. N., Ting, J., Lee, S., Lemyre, B., Wong, J., Afifi, J. K., Beltempo, M., & Shah, P. S. (2025) · PEDIATRICS · doi:10.1542/peds.2024-069102 · Cited by 51
van den Akker, C. H. P., Embleton, N. D., Lapillonne, A., Mihatsch, W., Salvatore, S., Canani, R. B., Dinleyici, E. Ç., Domellöf, M., Guarino, A., Gutiérrez‐Castrellón, P., et al. (2024) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.12204 · Cited by 45
Metadata
- Authors
- Kulkarni, T., Majarikar, S., Deshmukh, M., Ananthan, A., Balasubramanian, H., Keil, A., & Patole, S.
- Affiliations
- King Edward Memorial Hospital (AU)
- Fiona Stanley Hospital (AU)
- St John of God Subiaco Hospital (AU)
- King Edward Memorial Hospital and Seth G.S. Medical College (IN)
- Surya Hospitals (IN)
- The University of Western Australia (AU)
- Corresponding author
- Deshmukh, Mangesh
- ORCID
- Venue
- European Journal of Pediatrics
- Published
- 2022-03-29
- Volume
- 181
- Issue
- 6
- Pages
- 2249-2262
- ISSN
- 0340-6199 (ISSN-L)
- 1432-1076
- OpenAlex
- W4220670697
- Cited by
- 71
- References
- 57
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 13 · 2023: 17 · 2022: 4
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Pediatrics (publishedVersion, public-domain)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- preterm infants, probiotic prophylaxis, necrotizing enterocolitis, Bifidobacterium, Lactobacillus, Saccharomyces, neonatal mortality, antibiotic therapy, postbiotics, probiotic safety, central venous catheters, feeding intolerance, late-onset sepsis, all-cause mortality
- MeSH terms
- Anti-Bacterial Agents, Antifungal Agents, Humans, Infant, Infant, Newborn, Infant, Premature, Randomized Controlled Trials as Topic, Sepsis, Probiotics, Enterocolitis, Necrotizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotic sepsis in preterm neonates-a systematic review. https://app.cochat.ai/papers/10.1007/s00431-022-04452-5
- The paper
- Kulkarni, T., Majarikar, S., Deshmukh, M., Ananthan, A., Balasubramanian, H., Keil, A., & Patole, S. (2022). Probiotic sepsis in preterm neonates-a systematic review. European Journal of Pediatrics. https://doi.org/10.1007/s00431-022-04452-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.